Raltegravir (registered as Isentress) is now listed on the Pharmaceutical Benefits Scheme (PBS). People who have been accessing the drug via clinical trials or through compassionate access can now procure the treatment from hospital pharmacies, with a script by a HIV s100 prescribing doctor.